WEP Clinical Ltd (WEP), a specialist services company that works with drug developers to help patients and physicians gain early access to medicines, is pleased to announce the execution of a Master Services Agreement [...]
WEP Clinical today announced a partnership with Horizon Therapeutics plc to make a Named Patient Use (NPU) program available for TEPEZZA. The TEPEZZA NPU program is for patients with Thyroid Eye Disease (TED) in [...]
WEP Clinical (WEP) and Nabriva Therapeutics (Nabriva) are pleased to announce the expansion of the XENLETA® (lefamulin) Named Patient Program (NPP) into Australia, New Zealand, Singapore and South Africa. NPP is designed to ensure [...]
WEP Clinical (WEP) announced today that it has extended its partnership with BTG Specialty Pharmaceuticals (BTG), a division of Boston Scientific. Last year, WEP announced it would be partnering with BTG to supply the [...]
WEP Clinical (WEP) announced today that, as of July 2020, it has started a new Named Patient Program (NPP) on behalf of a US biotech company specializing in developing and commercializing novel oncology therapies. [...]
WEP Clinical (WEP) announced today that it has entered into a partnership with BTG Specialty Pharmaceuticals (BTG), a division of Boston Scientific. Under the terms of the partnership, WEP will manage the exclusive distribution [...]
WEP Clinical (WEP), a specialist pharmaceutical services company, has signed an exclusive agreement with Nabriva Therapeutics (Nabriva) to supply XENLETA® (lefamulin) on a named patient or expanded access basis. The Named Patient Program (NPP) [...]
WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to patients that have an unmet clinical need, is expanding its capabilities by making a strategic investment in Wren Healthcare Limited [...]
WEP Clinical (WEP), the specialist pharmaceutical services company, has partnered with Mylan N.V. (Mylan), a global pharmaceutical company, to launch a Named Patient Access Program (NPAP) for a new chemical entity used to treat [...]
WEP Clinical (WEP), the specialist pharmaceutical services company, is committed to helping businesses cope with the current COVID-19 crisis. As part of these efforts, WEP has recently partnered with Wren Healthcare (Wren), a UK-registered [...]